Extension Study of Idursulfase-IT Along With Elaprase in Children and Adults With Hunter Syndrome and Cognitive Impairment

PHASE2/PHASE3Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 5, 2024

Primary Completion Date

January 1, 2029

Study Completion Date

January 1, 2029

Conditions

Hunter Syndrome

Interventions

DRUG

Idursulfase-IT

Idursulfase-IT intrathecally via IDDD.

DRUG

Elaprase

Elaprase IV infusion.

Trial Locations (4)

M.A.G.I.C. Clinic, Calgary

University of British Columbia, Vancouver

Hospital for Sick Children, Toronto

Hopital Femme Mere Enfant, Bron